Organigram Global (OGI) Preferred Shares (2025 - 2026)
Organigram Global (OGI) posted quarterly Preferred Shares of $39.0 million for Q1 2026, down 1.09% quarter-over-quarter from $39.5 million in Q4 2025.
Organigram Global (OGI) Preferred Shares (2025 - 2026) Analysis & Trends
Organigram Global (OGI) has reported Preferred Shares for 2 consecutive years, with $39.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Preferred Shares changed N/A year-over-year to $39.0 million; the TTM figure through Mar 2026 stood at $39.0 million (changed N/A YoY), while the FY2025 annual figure was $39.5 million, changed N/A from the prior year.
- Preferred Shares eased to $39.0 million in Q1 2026 per OGI's latest filing, from $39.5 million in the prior quarter.
- Across five years, Preferred Shares topped out at $49.9 million in Q3 2025 and bottomed at $39.0 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Organigram Global | 158.95 Mn | 158.83 Mn | 28.97 Mn | 39.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 39.02 Mn |
| Dec 31, 2025 | 39.45 Mn |
| Sep 30, 2025 | 49.89 Mn |